BIOMERICA INC Operating Lease Cost
BIOMERICA INC (BMRA) reported Operating Lease Cost of $357.00 thousand for the 12-month period ending 2026-05-31, per its 10-K filed 2026-08-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-08-31
- BIOMERICA INC operating lease, cost for the quarter ending 2026-05-31 was $92.00K, a 4.55% increase year-over-year.
- BIOMERICA INC operating lease, cost for the quarter ending 2026-02-28 was $88.00K, a 0.00% change year-over-year.
- BIOMERICA INC operating lease, cost for the quarter ending 2025-11-30 was $88.00K, a 0.00% change year-over-year.
- BIOMERICA INC operating lease, cost for the quarter ending 2025-08-31 was $88.00K, a 0.00% change year-over-year.
- BIOMERICA INC operating lease, cost for fiscal 2026 was $357.00K, a 1.13% increase from fiscal 2025.
- BIOMERICA INC operating lease, cost for fiscal 2025 was $353.00K, a 0.00% change from fiscal 2024.
- BIOMERICA INC operating lease, cost for fiscal 2024 was $353.00K, a 0.00% change from fiscal 2023.
- BIOMERICA INC operating lease, cost for fiscal 2023 was $353.00K, a 0.28% increase from fiscal 2022.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-05-31 | $92.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-31 | $180.00K derived: sum of 2 quarters · filed 2026-08-31 | $268.00K derived: sum of 3 quarters · filed 2026-08-31 | $357.00K 10-K · filed 2026-08-31 |
| 2026-02-28 | $88.00K 10-Q · filed 2026-04-13 | $176.00K derived: sum of 2 quarters · filed 2026-04-13 | $265.00K 10-Q · filed 2026-04-13 | $352.00K derived: sum of 4 quarters · filed 2026-08-31 |
| 2025-11-30 | $88.00K 10-Q · filed 2026-01-14 | $176.00K 10-Q · filed 2026-01-14 | $264.00K derived: sum of 3 quarters · filed 2026-08-31 | $352.00K derived: sum of 4 quarters · filed 2026-08-31 |
| 2025-08-31 | $88.00K 10-Q · filed 2025-10-14 | $176.00K derived: sum of 2 quarters · filed 2026-08-31 | $264.00K derived: sum of 3 quarters · filed 2026-08-31 | $352.00K derived: sum of 4 quarters · filed 2026-08-31 |
| 2025-05-31 | $88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-31 | $176.00K derived: sum of 2 quarters · filed 2026-08-31 | $264.00K derived: sum of 3 quarters · filed 2026-08-31 | $353.00K 10-K · filed 2026-08-31 |
| 2025-02-28 | $88.00K 10-Q · filed 2026-04-13 | $176.00K derived: sum of 2 quarters · filed 2026-04-13 | $265.00K 10-Q · filed 2026-04-13 | $352.00K derived: sum of 4 quarters · filed 2026-04-13 |
| 2024-11-30 | $88.00K 10-Q · filed 2026-01-14 | $176.00K 10-Q · filed 2026-01-14 | $264.00K derived: sum of 3 quarters · filed 2026-01-14 | $352.00K derived: sum of 4 quarters · filed 2026-01-14 |
| 2024-08-31 | $88.00K 10-Q · filed 2025-10-14 | $176.00K derived: sum of 2 quarters · filed 2025-10-14 | $264.00K derived: sum of 3 quarters · filed 2025-10-14 | $352.00K derived: sum of 4 quarters · filed 2025-10-14 |
| 2024-05-31 | $88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-29 | $176.00K derived: sum of 2 quarters · filed 2025-08-29 | $264.00K derived: sum of 3 quarters · filed 2025-08-29 | $353.00K 10-K · filed 2025-08-29 |
| 2024-02-29 | $88.00K 10-Q · filed 2024-04-12 | $88.00K 10-Q · filed 2025-04-14 | $265.00K 10-Q · filed 2025-04-14 | $352.00K derived: sum of 4 quarters · filed 2025-01-14 |
| 2023-11-30 | $88.00K 10-Q · filed 2025-01-14 | $176.00K 10-Q · filed 2025-01-14 | $264.00K derived: sum of 3 quarters · filed 2025-01-14 | $352.00K derived: sum of 4 quarters · filed 2025-01-14 |
| 2023-08-31 | $88.00K 10-Q · filed 2024-10-15 | $176.00K derived: sum of 2 quarters · filed 2024-10-15 | $264.00K derived: sum of 3 quarters · filed 2024-10-15 | $352.00K derived: sum of 4 quarters · filed 2024-10-15 |
| 2023-05-31 | $88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-28 | $176.00K derived: sum of 2 quarters · filed 2024-08-28 | $264.00K derived: sum of 3 quarters · filed 2024-08-28 | $353.00K 10-K · filed 2024-08-28 |
| 2023-02-28 | $88.00K 10-Q · filed 2024-04-12 | $176.00K derived: sum of 2 quarters · filed 2024-04-12 | $265.00K 10-Q · filed 2024-04-12 | |
| 2022-11-30 | $88.00K 10-Q · filed 2024-01-16 | $176.00K 10-Q · filed 2024-01-16 | ||
| 2022-08-31 | $88.00K 10-Q · filed 2023-10-12 | |||
| 2022-05-31 | $352.00K 10-K · filed 2023-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |